{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T04:07:53Z","timestamp":1791691673597,"version":"4.3.4"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>Although immunohistochemistry (IHC) has improved our ability to detect melanoma metastases in sentinel lymph nodes (SLN), the American Joint Committee on Cancer (AJCC) does not provide a lower threshold for determining if a SLN is positive for metastasis. Existing literature suggests that even a small aggregate or an enlarged, abnormal cell detectable by IHC can be associated with an adverse outcome. In our experience, however, some SLNs contain small solitary cells the size of neighboring lymphocytes demonstrable only by IHC. We sought to determine their clinical significance. A total of 821 patients underwent a SLN biopsy at our institution over a 12-year period. In all, 639 (77.8%) were SLN-negative, 125 (15.2%) were SLN-positive, and 57 (6.9%) had rare IHC-positive cells of undetermined clinical significance with no disease progression over a mean 59-month follow-up. Kaplan-Meier method with pair-wise comparisons revealed no significant difference in disease-specific survival and recurrence-free survival between SLN-negative and rare IHC-positive groups. There were significant differences in survival and recurrence between patients in the rare IHC-positive group and those with melanoma metastases, including those with solitary melanoma cells and those with tumor burdens \u22640.2\u2009mm. While the lower diagnostic threshold for metastatic melanoma on IHC-stained sections needs to be studied further, our data suggest that rare IHC-positive cells lacking cytomorphologic features of overt malignancy are equivocal for melanoma and could impart a similar prognosis as patients with no evidence of SLN involvement.<\/jats:p>","DOI":"10.1097\/pas.0000000000001229","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T07:55:27Z","timestamp":1550735727000},"page":"755-765","source":"Crossref","is-referenced-by-count":9,"title":["Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for Melanoma"],"prefix":"10.1097","volume":"43","author":[{"given":"Robert E.","family":"LeBlanc","sequence":"first","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea T.","family":"Barton","sequence":"additional","affiliation":[{"name":"Surgery and Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongze","family":"Li","sequence":"additional","affiliation":[{"name":"Biostatistics Shared Resource, Norris Cotton Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina V.","family":"Angeles","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Ernstoff","sequence":"additional","affiliation":[{"name":"Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eryn","family":"Bagley","sequence":"additional","affiliation":[{"name":"Medicine, Hematology and Oncology Program, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wimmer","sequence":"additional","affiliation":[{"name":"Inform Diagnostics, Irving, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Wong","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Barth","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Shirai","sequence":"additional","affiliation":[{"name":"Medicine, Hematology and Oncology Program, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofeng","family":"Yan","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1245\/ASO.2003.09.016","article-title":"Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients","volume":"10","author":"Rousseau","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10434-000-0087-9","article-title":"Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0\u2009mm). Intergroup Melanoma Surgical Trial","volume":"7","author":"Balch","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10434-000-0469-z","article-title":"Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience","volume":"7","author":"Cascinelli","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","article-title":"Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases","volume":"28","author":"Balch","year":"2010","journal-title":"J Clin Oncol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00000478-200405000-00005","article-title":"False-positive rate of the immunoperoxidase stains for MART1\/MelanA in lymph nodes","volume":"28","author":"Yan","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/j.semdp.2008.03.001","article-title":"False-positive cells in sentinel lymph nodes","volume":"25","author":"Brennick","year":"2008","journal-title":"Semin Diagn Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jamcollsurg.2013.12.014","article-title":"Comparison of sentinel lymph node micrometastatic tumor burden measurements in melanoma","volume":"218","author":"Egger","year":"2014","journal-title":"J Am Coll Surg"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J Clin Oncol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bjps.2003.03.002","article-title":"Five years of sentinel node biopsy for melanoma: the St George\u2019s Melanoma Unit experience","volume":"57","author":"Topping","year":"2004","journal-title":"Br J Plast Surg"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1200\/JCO.2007.15.4179","article-title":"Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma","volume":"26","author":"Gershenwald","year":"2008","journal-title":"J Clin Oncol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2133.2007.07937.x","article-title":"Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection","volume":"157","author":"Debarbieux","year":"2007","journal-title":"Br J Dermatol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1245\/s10434-007-9734-8","article-title":"Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node","volume":"15","author":"Rossi","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/bjs.5814","article-title":"Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma","volume":"94","author":"van Akkooi","year":"2007","journal-title":"Br J Surg"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/SLA.0b013e318161312a","article-title":"Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma","volume":"247","author":"Guggenheim","year":"2008","journal-title":"Ann Surg"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1365-2559.2007.02681.x","article-title":"Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients","volume":"50","author":"Satzger","year":"2007","journal-title":"Histopathology"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/BF02574515","article-title":"Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy","volume":"9","author":"Ranieri","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1245\/ASO.2003.03.054","article-title":"The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance?","volume":"10","author":"Carlson","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.amjsurg.2006.08.062","article-title":"Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma","volume":"192","author":"Pearlman","year":"2006","journal-title":"Am J Surg"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejca.2013.08.023","article-title":"The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients","volume":"50","author":"van der Ploeg","year":"2014","journal-title":"Eur J Cancer"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1245\/s10434-011-2208-z","article-title":"Sentinel lymph nodes containing very small (<0.1\u2009mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative","volume":"19","author":"Murali","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1245\/s10434-007-9472-y","article-title":"Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma","volume":"14","author":"Scheri","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/PAS.0b013e3180341ebc","article-title":"Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes","volume":"31","author":"Satzger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/annonc\/mdl176","article-title":"Clinical relevance of melanoma micrometastases (<0.1\u2009mm) in sentinel nodes: are these nodes to be considered negative?","volume":"17","author":"van Akkooi","year":"2006","journal-title":"Ann Oncol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00000478-199607000-00006","article-title":"Nodal nevi and cutaneous melanomas","volume":"20","author":"Carson","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1097-0142(197701)39:1<164::AID-CNCR2820390127>3.0.CO;2-T","article-title":"Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance","volume":"39","author":"Ridolfi","year":"1977","journal-title":"Cancer"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1309\/Y5QAD623MYA21PUY","article-title":"Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi","volume":"121","author":"Holt","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1309\/JXE9EYQXD691LV2Y","article-title":"Nevus cell aggregates in lymph nodes","volume":"121","author":"Patterson","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1309\/AJCPG83CMAVFBWLC","article-title":"Clinical characteristics and survival data of melanoma patients with nevus cell aggregates within sentinel lymph nodes","volume":"139","author":"Gambichler","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.prp.2015.01.003","article-title":"Lymph node melanocytic nevi: pathogenesis and differential diagnoses, with special reference to p16 reactivity","volume":"211","author":"Piana","year":"2015","journal-title":"Pathol Res Pract"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/00000478-200210000-00012","article-title":"Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma","volume":"26","author":"Lohmann","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00000478-200305000-00011","article-title":"Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma","volume":"27","author":"Biddle","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ajcp\/102.1.102","article-title":"Benign melanocytic nevus cells in axillary lymph nodes. A prospective incidence and immunohistochemical study with literature review","volume":"102","author":"Bautista","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/ajcp\/55.1.88","article-title":"Primary nevus of a lymph node","volume":"55","author":"Hart","year":"1971","journal-title":"Am J Clin Pathol"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/1097-0142(196903)23:3<747::AID-CNCR2820230331>3.0.CO;2-9","article-title":"Benign nevus cells in the capsule of lymph nodes","volume":"23","author":"Johnson","year":"1969","journal-title":"Cancer"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000372-200202000-00001","article-title":"Nevus cells in lymph nodes: an association with congenital cutaneous nevi","volume":"24","author":"Fontaine","year":"2002","journal-title":"Am J Dermatopathol"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24047","article-title":"The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution","volume":"115","author":"Ludgate","year":"2009","journal-title":"Cancer"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1525-1470.2009.01078.x","article-title":"Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults\u2014the Stanford experience 1995-2008","volume":"27","author":"Berk","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1245\/s10434-010-1022-3","article-title":"Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms","volume":"17","author":"Ghazi","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1245\/s10434-007-9577-3","article-title":"Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors)","volume":"15","author":"Murali","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1245\/s10434-006-9142-5","article-title":"Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features","volume":"13","author":"Gamblin","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0560.2011.01849.x","article-title":"An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis","volume":"39","author":"Abraham","year":"2012","journal-title":"J Cutan Pathol"},{"key":"R50-20230922","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/cup.12580","article-title":"Benign melanocytic lymph node deposits in the setting of giant congenital melanocytic nevi: the large congenital nodal nevus","volume":"42","author":"Bowen","year":"2015","journal-title":"J Cutan Pathol"},{"key":"R51-20230922","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1365-2559.2006.02437.x","article-title":"Positive sentinel node biopsy in a 30-month-old boy with atypical Spitz tumour (Spitzoid melanoma)","volume":"48","author":"Urso","year":"2006","journal-title":"Histopathology"},{"key":"R52-20230922","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ijc.31037","article-title":"Blood monocytes sample MelanA\/MART1 antigen for long-lasting cross-presentation to CD8(+) T cells after differentiation into dendritic cells","volume":"142","author":"Faure","year":"2018","journal-title":"Int J Cancer"},{"key":"R53-20230922","doi-asserted-by":"crossref","first-page":"e0134320","DOI":"10.1371\/journal.pone.0134320","article-title":"Macrophage-tumor cell fusions from peripheral blood of melanoma patients","volume":"10","author":"Clawson","year":"2015","journal-title":"PLoS One"},{"key":"R54-20230922","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/CMR.0000000000000361","article-title":"Histopathologic review of negative sentinel lymph node biopsies in thin melanomas: an argument for the routine use of immunohistochemistry","volume":"27","author":"Stowman","year":"2017","journal-title":"Melanoma Res"},{"key":"R55-20230922","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0889-8588(05)70021-6","article-title":"Classification and staging of melanoma","volume":"12","author":"Gershenwald","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"key":"R56-20230922","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<617::AID-CNCR10>3.0.CO;2-S","article-title":"Detection of microscopic melanoma metastases in sentinel lymph nodes","volume":"86","author":"Yu","year":"1999","journal-title":"Cancer"},{"key":"R57-20230922","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00000658-200102000-00015","article-title":"Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence","volume":"233","author":"Clary","year":"2001","journal-title":"Ann Surg"},{"key":"R58-20230922","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/cncr.20179","article-title":"Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision","volume":"100","author":"Abrahamsen","year":"2004","journal-title":"Cancer"},{"key":"R59-20230922","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jcp.2003.011742","article-title":"Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry","volume":"57","author":"Gietema","year":"2004","journal-title":"J Clin Pathol"},{"key":"R60-20230922","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1245\/s10434-008-9847-8","article-title":"Extensive pathological analysis of selected melanoma sentinel lymph nodes: high metastasis detection rates at reduced workload","volume":"15","author":"Riber-Hansen","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R61-20230922","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.pas.0000152134.36030.b7","article-title":"Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis","volume":"29","author":"Spanknebel","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R62-20230922","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/cncr.24268","article-title":"Stage migration after minor changes in histologic estimation of tumor burden in sentinel lymph nodes: the protocol trap","volume":"115","author":"Riber-Hansen","year":"2009","journal-title":"Cancer"},{"key":"R63-20230922","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.5858\/arpa.2012-0550-OA","article-title":"Lack of standards for the detection of melanoma in sentinel lymph nodes: a survey and recommendations","volume":"137","author":"Dekker","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R64-20230922","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jaad.2003.07.016","article-title":"Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?","volume":"50","author":"Karimipour","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 2","key":"R65-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0560.2008.01130.x","article-title":"Use of immunohistochemistry in melanocytic lesions","volume":"35","author":"Prieto","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R66-20230922","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1034\/j.1600-0560.2002.290703.x","article-title":"Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56\/N-CAM and GAP-43: evidence of early Schwann cell differentiation","volume":"29","author":"Trejo","year":"2002","journal-title":"J Cutan Pathol"},{"key":"R67-20230922","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cll.2017.05.002","article-title":"Sentinel lymph nodes in cutaneous melanoma","volume":"37","author":"Prieto","year":"2017","journal-title":"Clin Lab Med"},{"key":"R68-20230922","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PAI.0000000000000097","article-title":"SOX10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes","volume":"23","author":"Willis","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R69-20230922","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/DAD.0b013e3182042893","article-title":"Identification of nodal metastases in melanoma using sox-10","volume":"33","author":"Jennings","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"R70-20230922","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/PAI.0000000000000146","article-title":"Can SOX-10 or KBA.62 replace S100 protein in immunohistochemical evaluation of sentinel lymph nodes for metastatic melanoma?","volume":"24","author":"Vrotsos","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R71-20230922","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00844277","article-title":"Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections","volume":"413","author":"Colombari","year":"1988","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"R72-20230922","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000372-199113060-00004","article-title":"HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation","volume":"13","author":"Skelton","year":"1991","journal-title":"Am J Dermatopathol"},{"key":"R73-20230922","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/DAD.0000000000000939","article-title":"Fatty acid synthase and acetyl-CoA carboxylase are expressed in nodal metastatic melanoma but not in benign intracapsular nodal nevi","volume":"40","author":"Saab","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"R74-20230922","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/PAS.0b013e31818a64fb","article-title":"Benign nodal nevi frequently harbor the activating V600E BRAF mutation","volume":"33","author":"Taube","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R75-20230922","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/modpathol.2012.132","article-title":"Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas","volume":"26","author":"Chen","year":"2013","journal-title":"Mod Pathol"},{"key":"R76-20230922","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/cup.12564","article-title":"Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations","volume":"42","author":"Rodic","year":"2015","journal-title":"J Cutan Pathol"},{"key":"R77-20230922","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/modpathol.2014.99","article-title":"5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies","volume":"28","author":"Lee","year":"2015","journal-title":"Mod Pathol"},{"key":"R78-20230922","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/annonc\/mdi372","article-title":"Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome","volume":"16","author":"Romanini","year":"2005","journal-title":"Ann Oncol"},{"key":"R79-20230922","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1245\/ASO.2004.10.003","article-title":"Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance","volume":"11","author":"Gradilone","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"R80-20230922","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1200\/JCO.2006.09.4573","article-title":"Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis","volume":"25","author":"Mocellin","year":"2007","journal-title":"J Clin Oncol"},{"key":"R81-20230922","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1245\/s10434-016-5575-7","article-title":"Sentinel lymph node genes to predict prognosis in node-positive melanoma patients","volume":"24","author":"Hao","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R82-20230922","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/jdv.12722","article-title":"Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma","volume":"29","author":"Ito","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R83-20230922","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1200\/JCO.2005.03.2342","article-title":"Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma","volume":"24","author":"Scoggins","year":"2006","journal-title":"J Clin Oncol"},{"key":"R84-20230922","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jso.20415","article-title":"Sentinel lymph node biopsy in thin melanoma patients","volume":"93","author":"Hershko","year":"2006","journal-title":"J Surg Oncol"},{"key":"R85-20230922","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/ejso.2002.1366","article-title":"The role of molecular staging in malignant melanoma","volume":"29","author":"Prichard","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"R86-20230922","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00008390-200310000-00010","article-title":"Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods","volume":"13","author":"Rimoldi","year":"2003","journal-title":"Melanoma Res"},{"key":"R87-20230922","first-page":"17","article-title":"Assessment of melanoma-initiating cell markers and conventional parameters in sentinel lymph nodes of malignant melanoma","volume":"69","author":"Suzuki","year":"2015","journal-title":"Acta Med Okayama"},{"key":"R88-20230922","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00432-016-2323-0","article-title":"Prognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up","volume":"143","author":"Eigentler","year":"2017","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201906000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:47:34Z","timestamp":1695408454000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201906000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001229","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735770906.793569157","asserted-by":"object"}]},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}